Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
2(50.0%)
4Total
N/A(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07355634Not ApplicableRecruiting

Terraflora Daily Care and Gastrointestinal Health

Role: lead

NCT07408245Not ApplicableRecruiting

Effects of Biocidin on Oral Biofilms

Role: lead

NCT06640465Phase 2Completed

Comparing the Effects of Commercially Available Dietary Supplements on CoQ10 Concentrations

Role: lead

NCT07104929Phase 2Completed

Beta Glucan 500 and Biological Age and Immune Age

Role: lead

All 4 trials loaded